ArticleThe Journal of international medical research2026
Adherence and barriers to early discharge for patients with low-risk pulmonary embolism at a Latin American tertiary center: A retrospective cohort study.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo describe adherence to early discharge (<24 h) among patients with low-risk pulmonary embolism and to characterize barriers to its implementation.MethodsThis was a descriptive, retrospective cohort study conducted within an Anticoagulation Stewardship Program at a Colombian tertiary hospital. Low-risk pulmonary embolism was defined as simplified Pulmonary Embolism Severity Index of 0, absence of right ventricular dysfunction, and negative cardiac biomarkers. Outcomes at 30 days included mortality, major bleeding, and rehospitalization.ResultsAmong 765 patients with pulmonary embolism, 62 were classified as low risk. The median age was 45.5 years (interquartile range: 32-62) and 36/62 (58.1%) were women. Early discharge occurred in 13/62 patients (20.9%), whereas 49/62 (79.1%) experienced longer hospital stay (median, 3 days (interquartile range: 2-6)). Early discharge rates increased from 9.5% (2019-2022) to 45% (2022-2024). Thirty-day outcomes were favorable, with no deaths, major bleeding events, or rehospitalizations. Five patients revisited the emergency department for pain but did not require admission. Delayed discharge was more frequent in patients with anemia, thrombocytopenia, those receiving medications associated with increased bleeding risk, and in those managed outside the internal medicine service. Documented reasons for delayed discharge included awaiting echocardiography (12/49), international normalized ratio monitoring (11/49), other comorbidities (11/49), delayed direct oral anticoagulants dispensing or authorization (9/49), and uncontrolled pain (6/49).ConclusionsAdherence to early discharge for low-risk pulmonary embolism was limited despite excellent short-term safety outcomes. System- and process-level barriers, particularly echocardiography utilization, warfarin/international normalized ratio requirements, direct oral anticoagulants access, and pain management, may be addressed through standardized discharge pathways and diagnostic stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.